Potential mechanisms of estrogen quinone carcinogenesis.
about
Cancer Activation and Polymorphisms of Human Cytochrome P450 1B1Alcohol drinking and mammary cancer: Pathogenesis and potential dietary preventive alternativesLeukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanismA perspective on the role of estrogen in hormone-induced prostate carcinogenesisContinuing to illuminate the mechanisms underlying UV-mediated melanomagenesisFormation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective EffectsHuman aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbonsAbsolute configurations of DNA lesions determined by comparisons of experimental ECD and ORD spectra with DFT calculationsThe Role of Human Aldo-Keto Reductases in the Metabolic Activation and Detoxication of Polycyclic Aromatic Hydrocarbons: Interconversion of PAH Catechols and PAH o-QuinonesAnalysis of estrogens in serum and plasma from postmenopausal women: past present, and futureBalance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones.Analysis of endogenous glutathione-adducts and their metabolites.Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells.Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study.Breast fine-needle aspiration malondialdehyde deoxyguanosine adduct in breast cancer.Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice.hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifenQuantitative detection of 4-hydroxyequilenin-DNA adducts in mammalian cells using an immunoassay with a novel monoclonal antibody.SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.NMR and computational studies of stereoisomeric equine estrogen-derived DNA cytidine adducts in oligonucleotide duplexes: opposite orientations of diastereomeric formsRedox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesActivation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity.Selective estrogen receptor modulators: tissue specificity and clinical utility.Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugationMorphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptorsQuinone Methide Bioactivation Pathway: Contribution to Toxicity and/or Cytoprotection?Evaluation of Antitrypanosomal Dihydroquinolines for Hepatotoxicity, Mutagenicity, and Methemoglobin Formation In VitroLoss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female miceEndocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action.A multistage association study identifies a breast cancer genetic locus at NCOA7.Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells.The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sitesStructural determinant of chemical reactivity and potential health effects of quinones from natural productsProbing for DNA damage with β-hairpins: similarities in incision efficiencies of bulky DNA adducts by prokaryotic and human nucleotide excision repair systems in vitromiR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A).The effects of resveratrol and selected metabolites on the radiation and antioxidant response.The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.Dietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγ
P2860
Q26749242-85EDD981-1068-450F-AD52-81DB30C0C2D1Q26825714-21A8AF74-A9DC-4FB1-AD20-EAFDDFB38CB2Q26830271-25214063-F6A1-4BDF-A244-F71BF05E1BAEQ27004552-CC2EC933-56FA-4015-BFD4-429E3D6C38A3Q27026261-617DD3EA-CB91-43F7-AFA8-CC638F6338F5Q28468284-5D7D86F7-4D47-499B-A2D0-20F8C11DD1CAQ28651791-A49AA363-7D4F-4816-9934-11FAEA93F921Q28659270-2BB94593-068E-423C-80DB-85015A2544BCQ28712007-5BCF8704-A8AB-4CC5-8CF7-33C66EE98860Q30432877-B5834B03-1467-4890-877D-B78B906CAD04Q33396534-7B2A4CB2-4032-4293-91FA-A9AE5635A5B6Q33519106-A77A5FC2-5A31-4A8B-A9BF-6D950F19B354Q33622549-12830C62-9346-4BE5-9440-6F9168FE3ACEQ33739664-C676605C-B338-4CF2-B728-92E581B886D2Q33798380-B340DFB4-7214-4B66-A6A9-BFDA656EA721Q33837788-5740B35E-4D20-425A-A721-064D5E16C9DCQ33889266-2B468906-7739-45B4-A949-87EF5D74B7C5Q33959481-E81164C8-3796-40B1-A091-9274C740C868Q34024966-9FAF2FF8-E401-4250-81BD-47AFA8DD88C7Q34046551-875FA257-9D0E-4FC8-9BBB-50BDD209AB42Q34069244-15DFD46D-C786-4118-9891-D2DC0F13A941Q34119028-B6C0B10D-0C68-4686-97B6-35782B0A77F2Q34132197-36FE1A70-97A4-40EB-94DB-B2C0BA72CB17Q34134828-FCFF2045-DA56-4E31-9D4A-76A57BA13862Q34138965-D269F019-BB72-4FC1-A382-7D0E8ACF56BCQ34148850-D573D666-3CE8-47AD-A4F5-229DA6D55C1DQ34378297-332C345C-7867-41E2-B287-9722AF68A691Q34498904-E743D398-B788-4A72-82E4-DACF3B35F3D0Q35034369-60D18B11-C9E7-40CB-8010-51F854B129C2Q35057858-0AF1ACDE-8A92-4B46-A159-2067706217F8Q35108072-B5B5D785-84E9-4E25-99A2-B12A9AB8A233Q35144535-02129A41-80BF-4B56-BB51-C0963B5AB7F9Q35179559-2C043CAE-D387-434E-ADED-1E49908CD7CEQ35226221-0AF43977-B9C6-43F3-BF34-31DB9B24C537Q35540743-9D513A0A-AA24-41DA-9811-1A0EB92548F3Q35562532-0C9C00CF-67D8-473F-BAE5-A3154D0203A7Q35656216-59AF09CA-6641-4CB5-B26A-285DA238854CQ35760933-46301FC2-9692-4CDA-BB42-360EFB1F1F30Q35869879-E2242BE5-969A-4CFE-8C35-75DCAA548789Q36029637-EBC40D78-AEA0-46D3-A4F9-E94A7F518351
P2860
Potential mechanisms of estrogen quinone carcinogenesis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Potential mechanisms of estrogen quinone carcinogenesis.
@ast
Potential mechanisms of estrogen quinone carcinogenesis.
@en
Potential mechanisms of estrogen quinone carcinogenesis.
@nl
type
label
Potential mechanisms of estrogen quinone carcinogenesis.
@ast
Potential mechanisms of estrogen quinone carcinogenesis.
@en
Potential mechanisms of estrogen quinone carcinogenesis.
@nl
prefLabel
Potential mechanisms of estrogen quinone carcinogenesis.
@ast
Potential mechanisms of estrogen quinone carcinogenesis.
@en
Potential mechanisms of estrogen quinone carcinogenesis.
@nl
P2860
P356
P1476
Potential mechanisms of estrogen quinone carcinogenesis.
@en
P2093
Gregory R J Thatcher
Judy L Bolton
P2860
P304
P356
10.1021/TX700191P
P577
2007-12-04T00:00:00Z